These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 26057410

  • 21. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
    Firriolo FJ, Hupp WS.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):431-41. PubMed ID: 22668425
    [Abstract] [Full Text] [Related]

  • 22. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 23. [New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients].
    Berthold HK.
    Z Gerontol Geriatr; 2012 Aug; 45(6):498-504. PubMed ID: 22828994
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.
    Baglin T, Keeling D, Kitchen S, British Committee for Standards in Haematology.
    Br J Haematol; 2012 Nov; 159(4):427-9. PubMed ID: 22970737
    [No Abstract] [Full Text] [Related]

  • 26. [New oral anticoagulants and digestive hemorrhages].
    Diallo I, Mallaret C, Jourdan S, Brardjanian S, Guisset M, Coton T.
    Presse Med; 2014 Jan; 43(1):85-7. PubMed ID: 23706679
    [No Abstract] [Full Text] [Related]

  • 27. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.
    Spyropoulos AC, Douketis JD, Gerotziafas G, Kaatz S, Ortel TL, Schulman S, Subcommittee on Control of Anticoagulation of the SSC of the ISTH.
    J Thromb Haemost; 2012 Apr 21; 10(4):692-4. PubMed ID: 22934291
    [No Abstract] [Full Text] [Related]

  • 33. New approaches to reversing oral anticoagulant therapy. Introduction.
    Nutescu EA.
    Am J Health Syst Pharm; 2013 May 15; 70(10 Suppl 1):S1-2. PubMed ID: 23640527
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW.
    Circulation; 2015 Mar 17; 131(11):972-9. PubMed ID: 25595139
    [Abstract] [Full Text] [Related]

  • 37. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.
    Int Angiol; 2014 Aug 17; 33(4):301-8. PubMed ID: 25056161
    [Abstract] [Full Text] [Related]

  • 38. Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison.
    Loke YK, Pradhan S, Yeong JK, Kwok CS.
    Br J Clin Pharmacol; 2014 Oct 17; 78(4):707-17. PubMed ID: 24617578
    [Abstract] [Full Text] [Related]

  • 39. Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
    Stief TW.
    Blood Coagul Fibrinolysis; 2012 Oct 17; 23(7):619-21. PubMed ID: 22821003
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.